Qualcomm CFO/COO executes 3,333-share sale via 10b5-1 plan
Rhea-AI Filing Summary
Akash J. Palkhiwala, identified as Chief Financial Officer & Chief Operating Officer of Qualcomm Inc. (QCOM), reported insider sales on 09/02/2025. The Form 4 shows four separate dispositions totaling 3,333 shares sold under a Rule 10b5-1 trading plan adopted on November 26, 2024. The reported sale price ranges across the four lots were approximately $155.38–$156.375, $156.385–$157.18, $157.385–$158.355, and $158.385–$158.865. Following these transactions the filer’s beneficial ownership is reported as 39,874 shares.
Positive
- Transactions executed under a Rule 10b5-1 trading plan, providing an affirmative defense against insider trading claims
- Form 4 discloses post-transaction beneficial ownership and is filed with a signature by attorney-in-fact, indicating procedural completeness
Negative
- Insider sold 3,333 shares, reducing reported beneficial ownership to 39,874 shares
- Sales occurred at market prices across ranges up to $158.865, representing realized dispositions by a senior executive
Insights
TL;DR Insider sales of 3,333 QCOM shares executed under a pre-established 10b5-1 plan; holding reduced to 39,874 shares.
The transactions are routine dispositions executed under a Rule 10b5-1 plan, which typically indicates pre-scheduled selling rather than discretionary trades. The total number of shares sold, 3,333, represents the factual change in the reporting person’s holdings. Price ranges for each lot are disclosed; no options or derivative exercises are reported. From an earnings or capital-structure perspective, these sales do not, by themselves, indicate a material change to Qualcomm’s financial condition.
TL;DR Sales executed pursuant to a 10b5-1 plan provide affirmative defense and signal procedural compliance in insider trading.
The filer explicitly states the trades were made under a 10b5-1 trading plan adopted on November 26, 2024, which supports compliance with insider trading rules. The Form 4 is properly signed by an attorney-in-fact and discloses post-transaction beneficial ownership. No amendments or additional governance concerns are indicated within the filing.